FLCCC Alliance Statement on Misleading FDA Guidance on Ivermectin
WASHINGTON, D.C. — The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, is troubled by the recently updated consumer guidance on Ivermectin from the FDA. The guidance from the FDA is misleading and has the potential to raise unwarranted concern over an important drug in the prevention and treatment of COVID-19.
https://covid19criticalcare.com/wp-c...arch7-2021.pdf